Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
University of Miami
ClinicalTrials.gov Identifier:
NCT00681343
First received: May 19, 2008
Last updated: May 23, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
No publications provided by University of Miami

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):